GenMark Diagnostics (GNMK)
Add to Watchlists Create an AlertGNMK Key Stats
| Income Statement | |
| Revenue TTM | 20.47M |
| Revenue Quarterly YoY Growth | 364.3% |
| EPS Diluted TTM | -0.8878 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -22.10M |
| Profitability | |
| Gross Profit Margin Quarterly | 49.57% |
| Profit Margin Quarterly | -49.70% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 484.02M |
| Enterprise Value | 429.87M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 8.574 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.0124 |
| Free Cash Flow | -4.338M |
| Return on Equity | -46.27% |
GNMK News
- Nasdaq stocks posting largest percentage increases May 20
- GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2013 Healthc... May 10
- GenMark Diagnostics Beats on Both Top and Bottom Lines May 9
- GenMark Diagnostics Earnings: Everything You Must Know Now May 8
- GenMark Diagnostics (GNMK) Tops Q1 EPS by 4c Street Insider May 8
- GenMark Diagnostics Reports First Quarter 2013 Results Business Wire May 8
- GENMARK DIAGNOSTICS, INC. Files SEC form 8-K, Results of Operations and Financia... May 8
- Q1 2013 GENMARK DIAGNOSTICS INC Earnings Release - After Market Close May 8
- Genmark Diagnostics Earnings: Your Sneak Peek to the Big Announcement May 8
- GenMark Diagnostics Schedules First Quarter 2013 Financial Results Conference Ca... Apr 25
GNMK Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). GenMark Diagnostics is up 236.4% over the last year vs S&P 500 Total Return up 27.96%, Abiomed down 0.14%, and Medical Action Industries up 52.10%.
GNMK Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these GNMK related companies
Pro Ratings for GNMK
Pro Report PDF for GNMK
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download GNMK Pro Report PDF
Pro Strategies Featuring GNMK
Did GenMark Diagnostics make it into our Pro Portfolio Strategies?
GNMK Profile
Sector: Healthcare
Industry: Medical Devices
Other GNMK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GNMK | 14.77 | +0.11 | +0.75% | 484.02M |
